About 61% of patients with stage I or II dMMR colon cancer achieved a pathologic complete response after a single cycle of neoadjuvant pembrolizumab, new data revealed.
For every birdie made on the 15th hole, the Cologuard Classic by Exact Sciences will donate $1,500 to pay for a cancer survivor’s travel expenses to Tucson in 2026.
Anyone can get colorectal cancer. Doctors often don't know why it happens, but they know some of the things that make people more likely to get it. These include: Age. The disease is most common ...
A recent American Cancer Society report highlights the increasing incidence of colorectal cancer in young adults. Understanding risk factors and recognizing symptoms are crucial for early detection ...
Some results have been hidden because they may be inaccessible to you